Stockreport

Verastem Oncology Announces Pricing of Registered Direct Offering of $150 Million of Convertible Notes

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF BOSTON--(BUSINESS WIRE)-- Verastem, Inc., (Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve [Read more]